Prelude Therapeutics Inc
PRLD
5 insider filings · Latest: May 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Apr 23 6:50 PM | David P BonitaDirector, 10% Owner | Purchase | 2,815,315 | $4.44 | $12.5M | 1,126,126(I) | View → |
| Apr 21, 2026 | Apr 23 6:48 PM | ORBIMED ADVISORS LLCDirector, 10% Owner | Purchase | 2,815,315 | $4.44 | $12.5M | 1,126,126(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 4 4:10 PM | Charles Q MorrisChief Medical Officer | Grant/Award | 450,000 | $4.70 | 450,000(D) | View → |
| Apr 27, 2026 | Apr 28 5:14 PM | RA CAPITAL MANAGEMENT, L.P.10% Owner | Other (J) | 1,407,000 | $0.0001 | 1,407,000(I) | View → |
| Apr 21, 2026 | Apr 22 4:15 PM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Purchase | 2,252,252 | $0.0001 | 20,105,994(I) | View → |